Digoxin (2E2) Monoclonal Antibody, Cy3 Conjugated
Product Specifications
Background
Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat) .
Synonyms
Lanoxin.
Host
Mouse
Cross Reactivity
Others
Target
Digoxin
Clonality
Monoclonal
Isotype
IgG
Clone
2E2
Conjugation
Cy3
Source
Digoxin-BSA
Applications
IF (IHC-P)
Purification
Purified by Protein G.
Excitation Emission
512,550nm/570,615nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Cross Reactivity Details
Digoxin
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1009998-01 0.02 mg (E-Coli)
Recombinant Shewanella baltica UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)
Ask
View Details MBS1009998-02 0.02 mg (Yeast)
Recombinant Shewanella baltica UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)
Ask
View Details MBS1009998-03 0.1 mg (E-Coli)
Recombinant Shewanella baltica UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)
Ask
View Details 
MBS1009998-04 0.1 mg (Yeast)
Recombinant Shewanella baltica UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)
Ask
View Details MBS1009998-05 0.02 mg (Baculovirus)
Recombinant Shewanella baltica UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)
Ask
View Details